In vitro platforms for evaluating liver toxicity
暂无分享,去创建一个
Manjunath Hegde | Albert Gough | Lawrence Vernetti | Ahmet Bakan | Martin L Yarmush | Shyam Sundhar Bale | Abhinav Bhushan | O. B. Usta | D. L. Taylor | A. Bakan | M. Yarmush | N. Senutovitch | L. Vernetti | A. Gough | T. Shun | A. Bhushan | M. Hegde | S. Bale | R. Jindal | W. McCarty | I. Golberg | D Lansing Taylor | O Berk Usta | Nina Senutovitch | Rohit Jindal | William J McCarty | Inna Golberg | Richard DeBiasio | Tong Y Shun | R. Debiasio | D. L. Taylor | S. S. Bale | Rohit Jindal
[1] R. Tsien,et al. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein , 2004, Nature Biotechnology.
[2] Sarah Goodchild,et al. Engineering antibodies for biosensor technologies. , 2006, Advances in applied microbiology.
[3] Li Di,et al. The role of drug metabolizing enzymes in clearance , 2014, Expert opinion on drug metabolism & toxicology.
[4] A. Guillouzo,et al. Liver cell models in in vitro toxicology. , 1998, Environmental health perspectives.
[5] Anne E Carpenter,et al. Identification of small molecules for human hepatocyte expansion and iPS differentiation , 2013, Nature chemical biology.
[6] Thomas Singer,et al. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. , 2013, Toxicology and applied pharmacology.
[7] D. Taylor,et al. A fluorescent protein biosensor of myosin II regulatory light chain phosphorylation reports a gradient of phosphorylated myosin II in migrating cells. , 1995, Molecular biology of the cell.
[8] Luke P. Lee,et al. Microfluidic environment for high density hepatocyte culture , 2008, Biomedical microdevices.
[9] Luke P. Lee,et al. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. , 2007, Biotechnology and bioengineering.
[10] R. Fontana,et al. Mechanisms of drug-induced liver injury: from bedside to bench , 2011, Nature Reviews Gastroenterology &Hepatology.
[11] P Smith,et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.
[12] F Peter Guengerich,et al. Applying mechanisms of chemical toxicity to predict drug safety. , 2007, Chemical research in toxicology.
[13] Matthew H. M. Lim,et al. Perfused multiwell plate for 3D liver tissue engineering. , 2010, Lab on a chip.
[14] P. J. Lusby,et al. Getting harder: cobalt(III)-template synthesis of catenanes and rotaxanes. , 2009, Journal of the American Chemical Society.
[15] Cynthia A Afshari,et al. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[16] Eric A G Blomme,et al. Toxicogenomics in drug discovery: from preclinical studies to clinical trials. , 2004, Chemico-biological interactions.
[17] C. Laggner,et al. Why drugs fail--a study on side effects in new chemical entities. , 2005, Current pharmaceutical design.
[18] Robert E Campbell,et al. New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. , 2002, Journal of the American Chemical Society.
[19] R Y Tsien,et al. Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[21] J. Kelm,et al. Multi-cell type human liver microtissues for hepatotoxicity testing , 2012, Archives of Toxicology.
[22] E. Verpoorte,et al. An alternative approach based on microfluidics to study drug metabolism and toxicity using liver and intestinal tissue , 2010 .
[23] Alexander Amberg,et al. EU framework 6 project: predictive toxicology (PredTox)--overview and outcome. , 2011, Toxicology and applied pharmacology.
[24] P. Ganey,et al. Intrinsic versus Idiosyncratic Drug-Induced Hepatotoxicity—Two Villains or One? , 2010, Journal of Pharmacology and Experimental Therapeutics.
[25] P. Moghe,et al. Mechanochemical manipulation of hepatocyte aggregation can selectively induce or repress liver-specific function. , 2000, Biotechnology and bioengineering.
[26] R. Taub. Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.
[27] A. Kalgutkar,et al. Minimising the potential for metabolic activation in drug discovery , 2005, Expert opinion on drug metabolism & toxicology.
[28] Peter Greaves,et al. First dose of potential new medicines to humans: how animals help , 2004, Nature Reviews Drug Discovery.
[29] M. Yarmush,et al. Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human. , 2009, Biochemical pharmacology.
[30] D. Keppler. The Roles of MRP2, MRP3, OATP1B1, and OATP1B3 in Conjugated Hyperbilirubinemia , 2014, Drug Metabolism and Disposition.
[31] P. Bernardi,et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.
[32] Russell A. Wilke,et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges , 2008, Nature Reviews Drug Discovery.
[33] F. Yi,et al. Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy , 2012, Protein & Cell.
[34] Robert E Campbell,et al. Genetically encoded biosensors based on engineered fluorescent proteins. , 2009, Chemical Society reviews.
[35] Amy Roe,et al. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[36] E L LeCluyse,et al. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[37] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.
[38] Vikram Sinha,et al. In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective , 2009, Drug Metabolism and Disposition.
[39] R. M. Lightfoot,et al. Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes. , 1999, The Journal of pharmacology and experimental therapeutics.
[40] M. Yarmush,et al. Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance , 2009, Proceedings of the National Academy of Sciences.
[41] X Liu,et al. Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[42] Kazuki Tainaka,et al. A single circularly permuted GFP sensor for inositol-1,3,4,5-tetrakisphosphate based on a split PH domain. , 2009, Bioorganic & medicinal chemistry.
[43] Melvin E. Andersen,et al. Organotypic liver culture models: Meeting current challenges in toxicity testing , 2012, Critical reviews in toxicology.
[44] S. Bhatia,et al. Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro , 2009, Hepatology.
[45] W. Maddrey. Drug-induced hepatotoxicity: 2005. , 2005, Journal of clinical gastroenterology.
[46] Alexander Tropsha,et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. , 2010, Chemical research in toxicology.
[47] Hayley S. Brown,et al. Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.
[48] K. V. Van Vliet,et al. Modulation of hepatocyte phenotype in vitro via chemomechanical tuning of polyelectrolyte multilayers. , 2009, Biomaterials.
[49] D. Nageshwar Reddy,et al. Thinking outside the liver: induced pluripotent stem cells for hepatic applications. , 2013, World journal of gastroenterology.
[50] Yvonne Will,et al. Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[51] Albert Gough,et al. Cellular Systems Biology Applied to Preclinical Safety Testing: A Case Study of CellCiphrTM Profiling , 2008 .
[52] N. Kaplowitz. Drug-Induced Liver Injury: Introduction and Overview , 2013 .
[53] M. Morris,et al. Fluorescent Biosensors of Intracellular Targets from Genetically Encoded Reporters to Modular Polypeptide Probes , 2009, Cell Biochemistry and Biophysics.
[54] P. Olinga,et al. Precision-cut liver slices: a tool to model the liver ex vivo. , 2013, Journal of hepatology.
[55] R Y Tsien,et al. Understanding, improving and using green fluorescent proteins. , 1995, Trends in biochemical sciences.
[56] M. Rizzetto,et al. Textbook of Hepatology , 2007 .
[57] O. Fardel,et al. Down-Regulation of Organic Anion Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokine Interleukin , 2008 .
[58] PhRMA Survey on the Conduct of First‐in‐Human Clinical Trials Under Exploratory Investigational New Drug Applications , 2010, Journal of clinical pharmacology.
[59] Rhys D O Jones,et al. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach. , 2011, Journal of pharmaceutical sciences.
[60] P. Olinga,et al. Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[61] R. Andrade,et al. Drug-induced hepatotoxicity , 2003, The New England journal of medicine.
[62] K. Jemnitz,et al. Comparison of Human Hepatoma HepaRG Cells with Human and Rat Hepatocytes in Uptake Transport Assays in Order to Predict a Risk of Drug Induced Hepatotoxicity , 2013, PloS one.
[63] Ann Richard,et al. ACToR--Aggregated Computational Toxicology Resource. , 2008, Toxicology and applied pharmacology.
[64] M. Yarmush,et al. A microfluidic hepatic coculture platform for cell-based drug metabolism studies. , 2010, Biochemical pharmacology.
[65] David S. Wishart,et al. T3DB: a comprehensively annotated database of common toxins and their targets , 2009, Nucleic Acids Res..
[66] S. Thorgeirsson,et al. Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. , 1974, Pharmacology.
[67] H. Mcburney,et al. Land-based versus pool-based exercise for people awaiting joint replacement surgery of the hip or knee: results of a randomized controlled trial. , 2009, Archives of physical medicine and rehabilitation.
[68] Thierry Lavé,et al. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets. , 2011, Journal of pharmaceutical sciences.
[69] Malcolm Rowland,et al. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance. , 2011, Journal of pharmaceutical sciences.
[70] James A J Fitzpatrick,et al. Fluorogen-activating single-chain antibodies for imaging cell surface proteins , 2008, Nature Biotechnology.
[71] Cédric Merlot,et al. Computational toxicology--a tool for early safety evaluation. , 2010, Drug discovery today.
[72] P. Olinga,et al. Repair pathways evident in human liver organ slices. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[73] R. Tompkins,et al. Hepatocyte function and extracellular matrix geometry: long‐term culture in a sandwich configuration , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[74] Arun J. Sanyal,et al. Zakim and Boyer's Hepatology: A Textbook of Liver Disease , 2016 .
[75] L. Samson,et al. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. , 2005, Current drug metabolism.
[76] Neil Kaplowitz,et al. Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.
[77] N. Kaplowitz. Acetaminophen hepatoxicity: What do we know, what don't we know, and what do we do next? , 2004, Hepatology.
[78] L. Griffith,et al. A microfabricated array bioreactor for perfused 3D liver culture. , 2002, Biotechnology and bioengineering.
[79] Malcolm Rowland,et al. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach. , 2011, Journal of pharmaceutical sciences.
[80] R. Tsien,et al. Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators* , 2004, Journal of Biological Chemistry.
[81] Albert H Gough,et al. Early Safety Assessment Using Cellular Systems Biology Yields Insights into Mechanisms of Action , 2010, Journal of biomolecular screening.
[82] N. Chaffey. Red fluorescent protein , 2001 .
[83] D. B. Duignan,et al. Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites , 2010, Drug Metabolism and Disposition.
[84] I. Ghosh,et al. Split-protein systems: beyond binary protein-protein interactions. , 2011, Current opinion in chemical biology.
[85] Hongbin Yu,et al. Special Section on Prediction of Human Pharmacokinetic Parameters from In Vitro Systems Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac , 2013 .
[86] Laura J. Itle,et al. Microreactor Microfluidic Systems with Human Microsomes and Hepatocytes for use in Metabolite Studies , 2005, Biomedical microdevices.
[87] J. Waring,et al. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. , 2009, Toxicology letters.
[88] Ruili Huang,et al. Paradigm Shift in Toxicity Testing and Modeling , 2012, The AAPS Journal.
[89] W. M. Lee,et al. Drug-induced hepatotoxicity. , 1995, The New England journal of medicine.
[90] R. Paules,et al. Phenotypic anchoring: linking cause and effect. , 2003, Environmental health perspectives.
[91] Elisabeth Verpoorte,et al. Microfluidic biochip for the perifusion of precision‐cut rat liver slices for metabolism and toxicology studies , 2010, Biotechnology and bioengineering.
[92] Amy Roe,et al. The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective , 2003, Journal of clinical pharmacology.
[93] A. Persechini,et al. Novel fluorescent indicator proteins for monitoring free intracellular Ca2+. , 1997, Cell calcium.
[94] Helene Andersson,et al. Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities. , 2004, Lab on a chip.
[95] G. Ubeaud‐Séquier,et al. Implication of hepatic transporters (MDR1 and MRP2) in inflammation‐associated idiosyncratic drug‐induced hepatotoxicity investigated by microvolume cytometry , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[96] R. Tsien,et al. Fluorescent indicators for Ca2+based on green fluorescent proteins and calmodulin , 1997, Nature.
[97] Weida Tong,et al. Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps) , 2011, PLoS Comput. Biol..
[98] R. Tompkins,et al. Long‐Term in Vitro Function of Adult Hepatocytes in a Collagen Sandwich Configuration , 1991, Biotechnology progress.
[99] Peter V. Henstock,et al. Cellular imaging predictions of clinical drug-induced liver injury. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[100] E. Björnsson,et al. Drug‐induced liver injury: Hy's rule revisited , 2006, Clinical pharmacology and therapeutics.
[101] Weida Tong,et al. FDA-approved drug labeling for the study of drug-induced liver injury. , 2011, Drug discovery today.
[102] R. Hell,et al. Redesign of Genetically Encoded Biosensors for Monitoring Mitochondrial Redox Status in a Broad Range of Model Eukaryotes , 2014, Journal of biomolecular screening.
[103] Malcolm Rowland,et al. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. , 2011, Journal of pharmaceutical sciences.
[104] Tudor I. Oprea,et al. BDDCS Applied to Over 900 Drugs , 2011, The AAPS Journal.
[105] A. Snapir,et al. PhRMA Survey of Pharmacogenomic and Pharmacodynamic Evaluations: What Next? , 2012, Clinical pharmacology and therapeutics.
[106] Frank Stahl,et al. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[107] P. Olinga,et al. Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro. , 2006, Journal of hepatology.
[108] L. Griffith,et al. Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor. , 2002, Tissue engineering.
[109] M L Yarmush,et al. Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation , 1992, The Journal of cell biology.
[110] Yuichi Sugiyama,et al. Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development , 2009, The AAPS Journal.
[111] M. T. Donato,et al. Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[112] F. Oesch,et al. New Hepatocyte In Vitro Systems for Drug Metabolism: Metabolic Capacity and Recommendations for Application in Basic Research and Drug Development, Standard Operation Procedures , 2003, Drug metabolism reviews.
[113] Mehmet Toner,et al. Polyelectrolyte nano-scaffolds for the design of layered cellular architectures. , 2006, Tissue engineering.
[114] P. Olinga,et al. Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[115] R Y Tsien,et al. Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[116] J. Boyer,et al. The Liver: Biology and Pathobiology: Fifth Edition , 2009 .